The Journal of Neuroscience, April 18, 2007, 27(16):4424-4434; doi:10.1523/JNEUROSCI.5113-06.2007
Previous Article | Next Article 
Neurobiology of Disease
Brain-Derived Neurotrophic Factor Restores Synaptic Plasticity in a Knock-In Mouse Model of Huntington's Disease
Gary Lynch,1
Eniko A. Kramar,1
Christopher S. Rex,2
Yousheng Jia,1
Danielle Chappas,1
Christine M. Gall,2,3 and
Danielle A. Simmons1
Departments of 1Psychiatry and Human Behavior, 2Neurobiology and Behavior, and 3Anatomy and Neurobiology, University of California, Irvine, California 92617-4291
Correspondence should be addressed to Dr. Danielle A. Simmons, 101 Theory Drive, Suite 250, University of California, Irvine, CA 92612-1695. Email: simmonsd{at}uci.edu
Asymptomatic Huntington's disease (HD) patients exhibit memory and cognition deficits that generally worsen with age. Similarly, long-term potentiation (LTP), a form of synaptic plasticity involved in memory encoding, is impaired in HD mouse models well before motor disturbances occur. The reasons why LTP deteriorates are unknown. Here we show that LTP is impaired in hippocampal slices from presymptomatic HdhQ92 and HdhQ111 knock-in mice, describe two factors contributing to this deficit, and establish that potentiation can be rescued with brain-derived neurotrophic factor (BDNF). Baseline physiological measures were unaffected by the HD mutation, but LTP induction and, to a greater degree, consolidation were both defective. The facilitation of burst responses that normally occurs during a theta stimulation train was reduced in HD knock-in mice, as was theta-induced actin polymerization in dendritic spines. The decrease in actin polymerization and deficits in LTP stabilization were reversed by BDNF, concentrations of which were substantially reduced in hippocampus of both HdhQ92 and HdhQ111 mice. These results suggest that the HD mutation discretely disrupts processes needed to both induce and stabilize LTP, with the latter effect likely arising from reduced BDNF expression. That BDNF rescues LTP in HD knock-in mice suggests the possibility of treating cognitive deficits in asymptomatic HD gene carriers by upregulating production of the neurotrophin.
Key words: neurotrophin; long-term potentiation; polyglutamine; hippocampus; actin; dendritic spines
Received Sept. 29, 2006;
revised March 6, 2007;
accepted March 8, 2007.
Correspondence should be addressed to Dr. Danielle A. Simmons, 101 Theory Drive, Suite 250, University of California, Irvine, CA 92612-1695. Email: simmonsd{at}uci.edu
This article has been cited by other articles:

|
 |

|
 |
 
D. A. Simmons, C. S. Rex, L. Palmer, V. Pandyarajan, V. Fedulov, C. M. Gall, and G. Lynch
Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin mice
PNAS,
March 24, 2009;
106(12):
4906 - 4911.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Milnerwood and L. A. Raymond
Corticostriatal synaptic function in mouse models of Huntington's disease: early effects of huntingtin repeat length and protein load
J. Physiol.,
December 15, 2007;
585(3):
817 - 831.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Lauterborn, C. S. Rex, E. Kramar, L. Y. Chen, V. Pandyarajan, G. Lynch, and C. M. Gall
Brain-Derived Neurotrophic Factor Rescues Synaptic Plasticity in a Mouse Model of Fragile X Syndrome
J. Neurosci.,
October 3, 2007;
27(40):
10685 - 10694.
[Abstract]
[Full Text]
[PDF]
|
 |
|